Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)

NCT: NCT03918161 · COMPLETED

NCT IDNCT03918161
StatusCOMPLETED
Start Date2019-07-24
Completion2020-12-12
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

Brief Summary

: GREFFE\_ELASTO IRM will evaluate Magnetic Resonance Elastography (MRE) in renal transplant patients with suspected interstitial fibrosis/tubular atrophy lesions requiring biopsy graft sampling under ultrasound control. The main objective is to search a correlation between renal graft parenchymal elasticity values obtained in vivo by MRE, and the histological data of renal fibrosis by biopsy sampling, and providing a non-invasive tool capable of detecting and monitoring this development over time, making possible in the future to reduce the number of renal biopsies.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑